Clinical Trial Update: Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients [Phase 1]

View source ↗

Summary

Phase 1 study of Dimethoxbenzylidene Anabaseine in patients with schizophrenia and psychotic disorders has completed. The update notes completion of the trial b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Dimethoxbenzylidene Anabaseine (dimethoxbenzylidene anabaseine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Schizophrenia, Psychotic Disorders | Phase 1 | Status: COMPLETED